Prognozy (mln) dla Hisamitsu Pharmaceutical Co., Inc.
| Okres |
2024-02-28 |
2025-02-28 |
2026-02-28 |
2027-02-28 |
2028-02-28 |
2029-02-28 |
2030-02-28 |
| Przychód (średnia) |
142,500.00 |
154,000.00 |
165,500.00 |
172,000.00 |
181,000.00 |
189,000.00 |
195,500.00 |
| Przychód Δ r/r |
0.00% |
8.07% |
7.47% |
3.93% |
5.23% |
4.42% |
3.44% |
| Przychód (min) |
115,177.67 |
154,000.00 |
165,500.00 |
172,000.00 |
181,000.00 |
189,000.00 |
195,500.00 |
| Przychód (max) |
169,822.33 |
154,000.00 |
165,500.00 |
172,000.00 |
181,000.00 |
189,000.00 |
195,500.00 |
| EBITDA (średnia) |
21,890.55 |
23,657.15 |
25,423.76 |
26,422.27 |
27,804.83 |
29,033.78 |
30,032.29 |
| EBIT (średnia) |
16,553.48 |
17,889.38 |
19,225.27 |
19,980.34 |
21,025.83 |
21,955.15 |
22,710.22 |
| EBIT % |
11.62% |
11.62% |
11.62% |
11.62% |
11.62% |
11.62% |
11.62% |
| Zysk netto (średni) |
14,699.37 |
19,085.59 |
23,766.68 |
21,392.96 |
24,946.17 |
29,392.10 |
32,962.27 |
| Zysk netto % |
10.32% |
12.39% |
14.36% |
12.44% |
13.78% |
15.55% |
16.86% |
| EPS (średnia) |
199.40 |
258.90 |
322.40 |
290.20 |
338.40 |
398.71 |
447.14 |
| Liczba analityków (Przychody) |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
| Liczba analityków (EPS) |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
| symbol |
4530.T |
4530.T |
4530.T |
4530.T |
4530.T |
4530.T |
4530.T |